Ads
related to: plaque psoriasis drug treatments- Treatment Option
Get Info On Treatment
Option. Learn More Today.
- Treatment Support
See Treatment Support Resources For
Questions About Costs, Dosing, etc.
- Insurance Coverage
Learn About Insurance Coverage &
Patient Support.
- Save on Prescription
Savings Program
2023 Program Requirements Apply.
- Safety Info
Learn About Safety &
Prescribing Info.
- Get Personalized Emails
Complete Form to Receive
Personalized Resources.
- Treatment Option
Search results
...Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA...
WTNH-TV New Haven· 3 days agoCLEAR-1 is global the first Phase 3 registration study in IL-23p19 class that reported over 80% of...
Psoriasis Tied to Increased Risk for MACE Despite Statin Use
Medscape· 1 day agoOver a period of 5 years, the likelihood of major adverse cardiovascular events (MACE) in patients...
Innovent’s psoriasis treatment picankibart meets all endpoints in Phase III trial
Clinical Trials Arena via Yahoo Finance· 3 days agoThe proportion of participants attaining a 90% or greater improvement from baseline Psoriasis...
Innovent to take IL-23 psoriasis drug to Chinese regulators after phase 3 win
FierceBiotech· 3 days agoThe anti-IL-23 monoclonal antibody, called picankibart, hit all primary and key secondary endpoints...
10 Science-Backed Benefits of Turmeric for Skin
Prevention via Yahoo News· 2 days agoIt may boost hair growth One study has shown that an extract of turmeric can help the hair loss drug Minoxidil penetrate deeper when applied topically,...
7 Biotech Stocks to Put on Your Breakthrough Radar
InvestorPlace· 4 days agoFor those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower....
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 6 days agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...
Swiss National Bank Cuts Stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
ETF DAILY NEWS· 6 days agoSwiss National Bank trimmed its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 9.8% in the 4th quarter, according to the company in its most recent Form ...
Ads
related to: plaque psoriasis drug treatments